EU to negotiate vaccine contract extension with Pfizer for an additional 1.8B doses through 2023

BRUSSELS — The head of the European Union’s executive arm has announced plans for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023.

European Commission President Ursula von der Leyen said Wednesday that the EU will start negotiating to buy 1.8 billion doses of the Pfizer-BioNTech vaccine through 2023.

The announcement came the same day that Denmark announced it will not resume the use of AstraZeneca’s COVID-19 vaccine, after reports that a handful of people who received it suffered rare and severe blood clots.

Pfizer has been a mainstay of the EU’s vaccination drive so far.

Von der Leyen expressed full confidence in the technology used for the Pfizer-BioNTech vaccine.

.Page-below > .RichTextModule {display:none;} .Page-below .Link {font-size: 12px; padding: 5px 10px;border: 1px solid #005687;border-radius: 4px;font-family: “proxima-nova”, sans-serif; }